With research, development, and cGMP facilities across North America, Europe, and India, Eurofins CDMO offers integrated global platforms for small molecules and biologics from formulation and development to manufacturing. Our expertise spans monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), high-potent APIs, solid state R&D, and API drug product and manufacturing.
Our interconnected teams of scientific experts work collaboratively across sites to help pharmaceutical and biotech companies overcome complexity and bring therapies to market faster — delivering on our mission to move medicine forward.
Want to learn more? Watch our video!
With strategically located facilities across North America, Europe and India, we are fully equipped to support your global drug development initiatives.
North America
Europe
India
Tuesday, 27/05/2025
Biologics brochure - Eurofins CDMO Alphora
Biologics services - North America
Tuesday, 09/07/2024
Eurofins CDMO Alphora Inc. (Canada) Announces Completion of New API Manufacturing FacilityEurofins CDMO is excited to announce an expansion of its API capacity and capabilities with the completion of its new API manufacturing facility.
Wednesday, 29/05/2024
Eurofins CDMO Alphora Inc. Announces the Launch of Expanded Drug Product Analytical LaboratoryEurofins CDMO Alphora Inc. is pleased to announce a significant expansion of its Drug Product Analytical Services Laboratory